Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Events After The Reporting Date (Tables)

v3.20.1
Events After The Reporting Date (Tables)
12 Months Ended
Dec. 31, 2018
Statement [LineItems]  
Summary of Options are Granted to Directors, Officers, Employees and Consultants

Options are granted to Directors, Officers, Employees and Consultants at various times. Options are to be settled by physical delivery of shares.

 

Grant date/Person entitled

   Number
of Options
    

Vesting Conditions

  

Contractual life
of Options

January 17, 2017, option grants to Employees

     277,519     

Vest as to 14 of the total number of Options granted, every year from Option Date

   7 years

February 7, 2017 option grants to Employees

     16,667     

Vest as to 1/4 of the total number of Options granted, every year from Option Date

   7 years

April 17, 2017, option grants to Employees

     50,000     

Vest as to 1/4 of the total number of Options granted, every year from Option Date

   7 years

September 7, 2017, options granted to Consultants

     6,667     

Half vest in 3 months and the remaining half in 6 months

   3 years

September 7, 2017, options granted to Directors

     12,269     

immediately

   7 years

September 15,2017, options granted to Consultants

     3,040     

immediately

   3 years

October 6, 2017, options granted to Consultants

     1,105     

immediately

   3 years

November 8, 2017 option grants to Employees

     18,950     

Vest as to 1/4 of the total number of Options granted, every year from Option Date

   7 years

December 4, 2017, options granted to Consultants

     1,948     

immediately

   3 years

December 4, 2017, options granted to Consultants

     6,667     

Half vest immediately and the remaining half in 12 months

   3 years

January 19, 2018 option grants to Employees

     273,948     

Options will vest the earlier of commercialization or 3 years from grant date

   7 years

July 6, 2018, options granted to Directors

     17,071     

immediately

   7 years

August 29, 2018, options granted to Directors

     31,498     

immediately

   7 years

December 18, 2018, options granted to Consultants

     50,349     

immediately

   3 years
Events After Reporting Period [member]  
Statement [LineItems]  
Summary of Options are Granted to Directors, Officers, Employees and Consultants

Options and the terms of each issue for the period from January 1, 2019 to date are outlined below.

 

Grant date/ Recipient

   Number
of Options
    

Vesting Conditions

  

Contractual Life
of Options

February 14, 2019, options granted to a Consultant

     40,000     

Options may vest over a 15-month vesting schedule

   Cancelled

May 29, 2019, options granted to a Director

     253,000     

Options vest over a specified vesting period not exceeding 4 years

   7 years

June 28, 2019, options granted to an Employee

     10,000     

Options vest as to 1/3 of the total number of Options granted, every year from Grant Date

   7 years

July 18, 2019, options granted to a Director

     25,719     

Options vest immediately

   7 years

July 19, 2019, options granted to an Employee

     467,255     

Options vest as to 1/4 of the total number of Options granted, every year from Grant Date

   7 years

July 19, 2019, options granted to a Consultant

     2,165     

Options vest as to 1/3 of the total number of Options granted, every year from Grant Date

   7 years

July 19, 2019, options granted to a Director

     41,273     

Options vest immediately

   7 years

September 9, 2019, options granted to a Consultant

     40,000     

Options vest over a 15-month vesting schedule subject to achieving certain milestones.

   2.5 years
Summary of shares sold under share purchase agreement

In the first quarter of 2020, Titan sold Common Shares to Aspire pursuant to the Aspire Agreement as outlined in the following table:

 

Grant Date

   Common
shares issued
     Value  

January 3, 2020

     500,000      $ 219,600  

January 6, 2020

     500,000        229,300  

January 8, 2020

     400,000        195,160  

January 10, 2020

     500,000        247,550  

January 17, 2020

     600,000        303,000  

January 23, 2020

     600,000        295,320  

February 6, 2020

     600,000        282,000  

February 13, 2020

     708,048        300,000  
  

 

 

    

 

 

 
     4,408,048      $ 2,071,930  
  

 

 

    

 

 

 

 

. Subsequent to August 29, 2019 and subject to the First Aspire Agreement, the Company issued Common Shares to Aspire as outlined in the following table:

 

Grant Date

   Common
shares issued
     Value  

August 30, 2019

     2,417,162      $ 3,000,000  

November 8, 2019

     100,000        42,560  

November 8, 2019

     100,000        42,560  

November 12, 2019

     100,000        42,970  

November 12, 2019

     100,000        42,000  

November 13, 2019

     100,000        42,970  

November 14, 2019

     300,000        128,910  

November 15, 2019

     2,500,000        1,074,250  

November 19, 2019

     2,067,282        888,311  
  

 

 

    

 

 

 
     7,784,444      $ 5,304,531